CN107209190B - 用于富集循环肿瘤dna的方法 - Google Patents

用于富集循环肿瘤dna的方法 Download PDF

Info

Publication number
CN107209190B
CN107209190B CN201580058989.4A CN201580058989A CN107209190B CN 107209190 B CN107209190 B CN 107209190B CN 201580058989 A CN201580058989 A CN 201580058989A CN 107209190 B CN107209190 B CN 107209190B
Authority
CN
China
Prior art keywords
nucleosomes
dna
histone
cancer
circulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580058989.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN107209190A (zh
Inventor
J.V.米卡莱夫
M.赫佐格
M.E.埃克莱斯顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Belgian Volition SPRL
Original Assignee
Belgian Volition SPRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54427791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN107209190(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB1419225.6A external-priority patent/GB201419225D0/en
Priority claimed from GB201419299A external-priority patent/GB201419299D0/en
Application filed by Belgian Volition SPRL filed Critical Belgian Volition SPRL
Priority to CN202010018617.1A priority Critical patent/CN111505305B/zh
Publication of CN107209190A publication Critical patent/CN107209190A/zh
Application granted granted Critical
Publication of CN107209190B publication Critical patent/CN107209190B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • G01N27/622—Ion mobility spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201580058989.4A 2014-10-29 2015-10-29 用于富集循环肿瘤dna的方法 Active CN107209190B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010018617.1A CN111505305B (zh) 2014-10-29 2015-10-29 用于富集循环肿瘤dna的方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1419225.6 2014-10-29
GBGB1419225.6A GB201419225D0 (en) 2014-10-29 2014-10-29 Method for the enrichment of circulating tumor DNA
GB1419299.1 2014-10-30
GB201419299A GB201419299D0 (en) 2014-10-30 2014-10-30 Method for the enrichment of circulating tumour DNA
PCT/GB2015/053238 WO2016067029A1 (en) 2014-10-29 2015-10-29 Method for the enrichment of circulating tumor dna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202010018617.1A Division CN111505305B (zh) 2014-10-29 2015-10-29 用于富集循环肿瘤dna的方法

Publications (2)

Publication Number Publication Date
CN107209190A CN107209190A (zh) 2017-09-26
CN107209190B true CN107209190B (zh) 2021-07-16

Family

ID=54427791

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201580058989.4A Active CN107209190B (zh) 2014-10-29 2015-10-29 用于富集循环肿瘤dna的方法
CN202010018617.1A Active CN111505305B (zh) 2014-10-29 2015-10-29 用于富集循环肿瘤dna的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202010018617.1A Active CN111505305B (zh) 2014-10-29 2015-10-29 用于富集循环肿瘤dna的方法

Country Status (12)

Country Link
US (2) US20180024141A1 (https=)
EP (2) EP3809140A1 (https=)
JP (1) JP6721599B2 (https=)
CN (2) CN107209190B (https=)
AU (1) AU2015340378B2 (https=)
CA (1) CA2965752C (https=)
DK (1) DK3213084T4 (https=)
ES (1) ES2839973T3 (https=)
IL (1) IL251896A0 (https=)
PL (1) PL3213084T3 (https=)
SG (2) SG10201903822XA (https=)
WO (1) WO2016067029A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2820129A1 (en) 2012-03-02 2015-01-07 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US11060145B2 (en) 2013-03-13 2021-07-13 Sequenom, Inc. Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
EP3736344A1 (en) 2014-03-13 2020-11-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CN106544341A (zh) * 2017-01-17 2017-03-29 上海亿康医学检验所有限公司 高效检测样本中的ctDNA的方法
WO2019053243A1 (en) 2017-09-18 2019-03-21 Santersus Sa METHOD AND DEVICE FOR PURIFYING BLOOD OF FREE CIRCULATING DNA
CN109932224A (zh) * 2017-12-18 2019-06-25 中国科学院大连化学物理研究所 一种富集提取循环肿瘤dna的方法
CN112119166B (zh) * 2018-03-13 2025-08-22 耶路撒冷希伯来大学伊萨姆研发有限公司 无细胞dna染色质免疫沉淀的诊断应用
CN112805563B (zh) * 2018-05-18 2025-06-13 约翰·霍普金斯大学 用于评估和/或治疗癌症的无细胞dna
GB201818963D0 (en) 2018-11-21 2019-01-09 Belgian Volition Sprl Methof for the detection of prostate cancer
GB201818965D0 (en) 2018-11-21 2019-01-09 Belgian Volition Sprl Method for the detection of colorectal cancer
CN109841265B (zh) * 2019-02-22 2021-09-21 清华大学 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用
GB201906201D0 (en) 2019-05-02 2019-06-19 Belgian Voltion Sprl Method for the detection of protate cancer
GB201906199D0 (en) 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
US12571051B2 (en) * 2019-08-27 2026-03-10 Belgian Volition Srl Method of isolating circulating nucleosomes
EP4041914A1 (en) * 2019-10-04 2022-08-17 Santersus AG Method for isolating and analyzing cell free dna
JP7349104B2 (ja) * 2019-11-13 2023-09-22 株式会社島津製作所 ベロ毒素の検出方法
IL293342B1 (en) 2019-12-02 2026-01-01 Belgian Volition Srl Using cell-free nucleosomes as biomarkers
WO2021236993A1 (en) * 2020-05-22 2021-11-25 Bloodq, Inc. Methods for characterizing cell-free nucleic acid fragments
GB202117799D0 (en) 2021-12-09 2022-01-26 Belgian Volition Srl Method for the detection of blood cancer
EP4453241A1 (en) * 2021-12-21 2024-10-30 Guardant Health, Inc. Methods and systems for combinatorial chromatin-ip sequencing
WO2023126672A1 (en) 2021-12-27 2023-07-06 Santersus Ag Method and device for removal of circulating cell free dna
EP4490323A1 (en) 2022-03-11 2025-01-15 Belgian Volition SRL Differential diagnosis method
WO2024042210A1 (en) * 2022-08-25 2024-02-29 Belgian Volition Srl Method for measuring cell free chromatin
EP4646208A1 (en) 2023-01-06 2025-11-12 Ideaya Biosciences, Inc. Treatment of er+ breast cancer comprising homologous recombination deficiency using parg inhibitor
WO2024223947A1 (en) 2023-04-28 2024-10-31 Belgian Volition Srl Use of cell free nucleosomes as biomarkers of carcinomas
GB202307768D0 (en) 2023-05-24 2023-07-05 Belgian Volition Srl Use of cell free nucleosomes as biomarkers
GB202310137D0 (en) 2023-07-03 2023-08-16 Belgian Volition Srl Method for the detection of cancer
WO2025012440A1 (en) 2023-07-13 2025-01-16 Belgian Volition Srl Method for detection of the potential of a body fluid sample to produce extracellular traps
WO2025061853A1 (en) 2023-09-19 2025-03-27 Belgian Volition Srl Lateral flow test device
WO2025073909A1 (en) 2023-10-04 2025-04-10 Belgian Volition Srl Pcr method for detecting ctcf occupied cfdna fragments
WO2025093747A1 (en) 2023-11-02 2025-05-08 Belgian Volition Srl Novel rapid high-throughput method of netosis induction and inhibition with physiologically relevant molecules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
US20060115482A1 (en) * 2004-04-27 2006-06-01 The Regents Of The University Of California Modifications of histone proteins as indicators of cell proliferation and differentiation
WO2007121276A2 (en) * 2006-04-12 2007-10-25 Biocept, Inc. Enrichment of circulating fetal dna
EP2062912A1 (en) * 2007-11-26 2009-05-27 Koninklijke Philips Electronics N.V. Selective enrichment of post-translationally modified proteins and/or peptides
US20100240054A1 (en) * 2008-09-22 2010-09-23 Biocept, Inc. Identification and isolation of fetal cells and nucleic acid
WO2010120942A2 (en) * 2009-04-14 2010-10-21 The Regents Of The University Of California Histone modification patterns for clinical diagnosis and prognosis of cancer
WO2013010181A2 (en) * 2011-07-14 2013-01-17 University Of Massachusetts Methods of diagnosing cancer using epigenetic biomarkers
GB201115095D0 (en) 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
EP2782928B1 (en) 2011-11-21 2017-01-04 The Royal Institution for the Advancement of Learning / McGill University Mutations of histone proteins associated with proliferative disorders
PT2788767T (pt) * 2011-12-07 2017-12-06 Belgian Volition Sprl Método de detecção de adutos de nucleosoma
EP2820129A1 (en) 2012-03-02 2015-01-07 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9388213B2 (en) * 2012-09-10 2016-07-12 The Rockefeller University Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof

Also Published As

Publication number Publication date
US20220334128A1 (en) 2022-10-20
PL3213084T3 (pl) 2021-07-26
SG10201903822XA (en) 2019-05-30
JP2017534300A (ja) 2017-11-24
US20180024141A1 (en) 2018-01-25
CN111505305B (zh) 2023-10-17
HK1243764A1 (en) 2018-07-20
CN111505305A (zh) 2020-08-07
IL251896A0 (en) 2017-06-29
EP3213084A1 (en) 2017-09-06
CA2965752C (en) 2024-04-02
CA2965752A1 (en) 2016-05-06
NZ731116A (en) 2024-03-22
EP3213084B2 (en) 2023-12-13
DK3213084T3 (da) 2021-01-18
WO2016067029A1 (en) 2016-05-06
ES2839973T3 (es) 2021-07-06
JP6721599B2 (ja) 2020-07-15
EP3213084B1 (en) 2020-11-25
CN107209190A (zh) 2017-09-26
EP3809140A1 (en) 2021-04-21
AU2015340378B2 (en) 2021-08-12
AU2015340378A1 (en) 2017-05-11
SG11201702978VA (en) 2017-05-30
DK3213084T4 (da) 2024-03-18

Similar Documents

Publication Publication Date Title
US20220334128A1 (en) Method for the enrichment of circulating tumor dna
US10746746B2 (en) Method for the enrichment of cell free nucleosomes
US12571051B2 (en) Method of isolating circulating nucleosomes
CN112119166B (zh) 无细胞dna染色质免疫沉淀的诊断应用
JP2019527361A (ja) 大腸癌の併用検査
JP6777757B2 (ja) 癌検出のためのヌクレオソーム−転写因子複合体の使用
US20240318255A1 (en) Transcription factor binding site analysis of nucleosome depleted circulating cell free chromatin fragments
TWI726009B (zh) 用親和純化法分析生物樣品中源自腫瘤之無細胞核小體、分離生物樣品中純化之腫瘤dna、檢測生物樣品中源自腫瘤之核小體表觀遺傳表位或在動物或人類受試者中檢測癌症之方法或包括組蛋白h1結合劑之套組之用途
HK40050636A (en) Method for the enrichment of circulating tumor dna
HK1243764B (en) Method for the enrichment of circulating tumor dna
HK40051192A (en) Method for the enrichment of cell free nucleosomes
HK1260172B (en) Method for the enrichment of cell free nucleosomes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant